Key facts
- This page summarizes Gregory Knutson's Form 4 filing for U.S. Stem Cell, Inc..
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Jul 2021, 16:02.
Gregory Knutson - 01 Apr 2020 Form 4 Insider Report for U.S. Stem Cell, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Apr 2020
- Net transaction value
- +$375,939,826,970
- SEC form
- 4
- Accepted by SEC
- 23 Jul 2021, 16:02:00 UTC
- Next SEC filing
- 04 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory Knutson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gregory Knutson filed Form 4 for U.S. Stem Cell, Inc. on 23 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$375,939,826,970.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
USRM
transaction
Common Stock
Other
- Transaction value
- $8,674
- Shares
- +1,445,647
- Change %
- +4.7%
- Price
- $0.006000
- Shares after
- 32,251,149
- Date
- 01 Apr 2020
- Ownership
- Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
- Footnotes
- F1
USRM
transaction
Common Stock
Other
- Transaction value
- $9,161
- Shares
- +2,035,820
- Change %
- +6.1%
- Price
- $0.004500
- Shares after
- 35,286,969
- Date
- 05 Oct 2020
- Ownership
- Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
- Footnotes
- F1
USRM
transaction
Common Stock
Other
- Transaction value
- $9,135
- Shares
- +187,575
- Change %
- +0.53%
- Price
- $0.0487
- Shares after
- 35,474,544
- Date
- 02 Apr 2021
- Ownership
- Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
- Footnotes
- F1
USRM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,675,000
- Date
- 01 Apr 2020
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
USRM
transaction
Derivative
Convertible promissory Note (right to buy)
Award
- Transaction value
- $375,939,800,000
- Shares
- +3,759,398
- Change %
- +104%
- Price
- $100000.00*
- Shares after
- 7,384,398
- Date
- 17 Feb 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,759,398
- Exercise price
- $0.0266
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Interest payment on outstanding debt.